Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.4376
-0.0040 (-0.89%)
Sep 15, 2025, 9:59 AM EDT - Market open
Harvard Bioscience Stock Forecast
HBIO's stock price has decreased by -84.4% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover Harvard Bioscience stock have a consensus rating of "Buy" and an average price target of $2.50, which forecasts a 471.23% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $3.00.
Price Target: $2.50 (+471.23%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Harvard Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Maintains $3 → $2 | Buy | Maintains | $3 → $2 | +356.99% | Sep 10, 2025 |
| Benchmark | Benchmark | Buy Maintains $4.5 → $3 | Buy | Maintains | $4.5 → $3 | +585.48% | May 13, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Benchmark | Benchmark | Buy Maintains $5.5 → $4.5 | Buy | Maintains | $5.5 → $4.5 | +928.22% | Mar 24, 2025 |
| Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +1,499.46% | Jun 22, 2023 |
Financial Forecast
Revenue This Year
87.21M
from 94.14M
Decreased by -7.36%
Revenue Next Year
93.43M
from 87.21M
Increased by 7.13%
EPS This Year
0.03
from -0.28
EPS Next Year
0.10
from 0.03
Increased by 280.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 91.4M | 100.6M |
| Avg | 87.2M | 93.4M |
| Low | 82.3M | 85.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | -3.0% | 15.3% |
| Avg | -7.4% | 7.1% |
| Low | -12.6% | -1.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.03 | 0.16 |
| Avg | 0.03 | 0.10 |
| Low | 0.02 | 0.04 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 517.6% |
| Avg | - | 280.0% |
| Low | - | 53.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.